Capitalisation Boursière Changement Date
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Celltrion KRW 45.1T 3.3T 2026-03
Cspc Pharmaceutical CNY 106.96B 74.01M 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
Exelixis USD 11.75B 959M 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Kangmei Pharma CNY 25.93B 2.01B 2026-03
Knight Therapeutics CAD 624.22M 38.25M 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 33.66M 28.87M 2026-03
Neuren Pharmaceuticals AUD 1.51B 851.62M 2026-03
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 265.66B 9.48B 2025-09
OPKO Health USD 2.59B 1.62B 2026-03
Organigram Holdings CAD 378.8M 132.2M 2025-09
Ovoca Bio EUR 7.54M 4.28M 2022-06
Pfizer USD 153.96B 12.4B 2026-03
Pharma Mar EUR 1.53B 184.71M 2026-03
PTC Therapeutics USD 6.1B 1.22B 2025-12
Qiagen NV USD 7.87B 2.03B 2026-03
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Sino Biopharmaceutical CNY 117.45B 27.39B 2026-03
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Zealand Pharma A/S 33.35B 0 2026-02
Zz Pientze Pharmaceu CNY 95.51B 23.22B 2026-03